Completed PHASE3 INTERVENTIONAL 4-arm NCT00000145

Age-Related Eye Disease Study (AREDS)

Sponsor: Bausch & Lomb Incorporated

Conditions Cataract Lens Opacities Macular Degeneration

Interventions Antioxidants Antioxidants and zinc Zinc

Updated 5 times since 2017 Last updated: Jan 21, 2009 Started: Sep 30, 1990 Primary completion: Oct 31, 2001 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cataract and Lens Opacities, this trial is completed. The trial is conducted by Bausch & Lomb Incorporated and has accumulated 5 data snapshots since 1990. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 1990

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch & Lomb Incorporated
National Eye Institute (NEI)

Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.